DHX9-Mediated Pathway Contributes to the Malignant Phenotype of Myelodysplastic Syndromes

The authors analyzed the expression of DHX9 and its clinical significance in 120 Myelodysplastic syndrome (MDS) patients and 42 non-MDS controls. Lentivirus-mediated DHX9 knockdown experiments were performed to investigate its biological function.